DAPAVIB M 10/500 DAPAGLIFLOZIN 10mg. IP + METFORMIN 500mg. IP

Dapavib M 10/500 tablets combine dapagliflozin 10 mg and metformin 500 mg to help control blood sugar in adults with type 2 diabetes. Main uses: adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus; helps lower blood sugar levels in adults with type 2 diabetes mellitus; in adults with type 2 diabetes mellitus and chronic kidney disease at risk of progression, the dapagliflozin component helps reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death and hospitalisation for heart failure; in adults with type 2 diabetes mellitus and heart failure, the dapagliflozin component helps reduce the risk of cardiovascular death and hospitalisation for heart failure; in adults with type 2 diabetes mellitus and established cardiovascular disease or multiple cardiovascular risk factors, the dapagliflozin component helps reduce the risk of hospitalisation for heart failure.

Common side effects of Dapavib M 10/500 Tablet include female genital fungal infection (thrush); urinary tract infection; nasopharyngitis (common cold, stuffy or runny nose); diarrhoea; nausea and vomiting; headache. Get medical help at once if you notice lactic acidosis from metformin, which can be life-threatening (symptoms may include malaise, muscle pain, breathing difficulty, drowsiness, abdominal pain); diabetic ketoacidosis, which can occur even when blood sugar is not very high; necrotising fasciitis of the perineum (Fournier's gangrene), a serious infection.

Each Dapavib M 10/500 tablet contains Dapagliflozin 10 mg + Metformin 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Dapavib M 10/500 Tablet only as your doctor advises.

The MRP of Dapavib M 10/500 Tablet is ₹136 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹103.62 and the PTS is ₹93.26.

Each Dapavib M 10/500 tablet contains Dapagliflozin 10 mg + Metformin 500 mg. It comes in a pack of 10x10 (Alu Alu).

Dapagliflozin works in the kidneys by cutting down the glucose that is reabsorbed back into the blood, so the extra sugar leaves the body through urine. Metformin acts on the liver to reduce the sugar it produces and helps the body use its own insulin more effectively. Used together, the two ingredients work in different ways to lower blood sugar.

Must not be used in patients with severe renal impairment (eGFR below 30 mL/min/1.73 m2) or end-stage renal disease. Must not be used in patients with acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. Must not be used by patients with a history of serious hypersensitivity reaction to dapagliflozin, metformin or any excipient of the tablet. Check with a doctor first if you have kidney problems, liver disease, dehydration or low blood volume, low blood pressure, or are taking diuretics. Check with a doctor first before use if you are elderly, drink alcohol heavily, are pregnant or breastfeeding, are undergoing surgery or contrast imaging, or get repeated urinary or genital infections.

Dapavib M 10/500 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.